Peer-reviewed articles

Urothelial Cancer Awareness Month Home Page

Expression of HER2 in urothelial carcinoma and its significance

Emerging strategies: conservative management of upper tract urothelial carcinoma

Novel Computational Pipeline Enables Reliable Diagnosis of Inverted Urothelial Papilloma and Distinguishes It From Urothelial Carcinoma

Differences in the expression heterogeneity of ADC-related markers between primary tumors and metastatic lymph nodes in advanced urothelial cancers.

Germline genetic variants in cancers of the bladder, renal pelvis, ureter, or urethra.

Real world effectiveness of systemic treatment in patients (pts) with advanced upper tract urothelial carcinoma (UTUC) with histological variants.

Reappraisal of clinicopathological relevance of RON expression in upper tract urothelial carcinoma

The biologic landscape and therapeutic implications of upper tract urothelial cancer

Germline genetic variants in cancers of the urothelial tract and association with outcomes

Immune checkpoint inhibitors (ICIs) in advanced upper tract urothelial cancer (UTUC) with mismatch repair deficiency (dMMR) or microsatellite instability (MSI).

Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma

Utilization of neoadjuvant chemotherapy (NAC) and pathologic outcomes in upper tract urothelial carcinoma (UTUC).

Predictors and patterns of non-urothelial recurrence after nephroureterectomy for upper tract urothelial carcinoma (UCAN Collaboration)

Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel